CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process.
Information about the trials listed below is provided by the CTN.
Small-scale CTN funded studies that are enrolling participants:
CTNPT 001: Fracture case-control study in HIV
CTNPT 002: Impact of counselling on sexual risk behaviours
CTNPT 003: Bone and renal outcomes in tenofovir-exposed infants
CTNPT 004: Effects of HLA allele frequencies on HIV disease progression
CTNPT 005: Measuring cognition in HIV [NEW]
CTNPT 006: The Niaspan® study [NEW]
CTNPT 011: Monitoring penicillin levels for syphilis [NEW]
CTNPT 014: Combination therapy for the management of HIV infection in the setting of HCV co-infection [NEW]
CTN studies that are enrolling participants:
CTN 260: Raltegravir switch study [NEW]
CTN 257: Impact of HIV on mucosa
CTN 256: Phase IIB study of efficacy and safety of AGS-004
CTN 254: Inflammation as a predictor of HIV disease progression
CTN 248: Incentives Stop AIDS & HIV in Drug Users [NEW]
CTN 247: Canadian cohort of HIV+ slow progressors
CTN 244: STOP HIV & AIDS in IDU
CTN 240: Valacyclovir in delaying antiretroviral treatment entry (VALIDATE) trial
CTN 238: The MAINTAIN study
CTN 236: HPV vaccine in HIV positive girls and women
CTN 222: Canadian co-infection cohort